Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs
John R Jones, Amy Barber, Yann‐Vaï Le Bihan, Niels Weinhold, Cody Ashby, Brian A. Walker, Christopher P. Wardell, Hannah Wang, Martin Kaiser, G. H. Jackson, Faith E. Davies, Rajesh Chopra, Gareth J. Morgan, Charlotte Pawlyn
Topics & Concepts
CereblonGeneDrug resistanceBiologyMedicineGeneticsUbiquitin ligaseUbiquitinProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysHistone Deacetylase Inhibitors Research